Table 6.
Scores from assessment of the vessel wall after treatment including injury, fibrosis, endothelilal cell loss, thrombus formation, and neointima formation (Mean ± SD, median and incidence) of vessel wall assessments
| Parameter | Day 90 treated | |||
|---|---|---|---|---|
| CHA (n = 5) | LRA and RRA (n = 10) | |||
| Injury | 0.00 ± 0.00 | 0% | 0.33 ± 0.69 | 20% |
| 0.00 | 0.00 | |||
| Fibrosis | 0.88 ± 0.28 | 100% | 0.86 ± 0.65 | 90% |
| 0.83 | 0.75 | |||
| Endothelial cell loss | 0.20 ± 0.45 | 20% | 0.00 ± 0.00 | 0% |
| 0.00 | 0.00 | |||
| Thrombus formation | 0.00 ± 0.00 | 0% | 0.00 ± 0.00 | 0% |
| 0.00 | 0.00 | |||
| Neointima | 0.30 ± 0.23 | 80% | 0.40 ± 0.44 | 50% |
| 0.33 | 0.25 | |||
CHA common hepatic artery, LRA left renal artery, RRA right renal artery
Vessel wall assessments: 0 = none; 1 = (minimal) < 25% of the circumference; 2 = (mild) 25–50% of the circumference; 3 = (moderate) 51–75% of the circumference; 4 = > 75% of the circumference